Application no. and date | 18722830.9 (espacenet) (Federated) (European Patent Register), 20180416 | Patent/reg. no. and date | DK/EP 3609540, 20230111 | Publication date | 20200219 | Priority no. and date | US 201762485899 P, 20170414, US 201762526347 P, 20170628, WO PCT/US2017/041268, 20170707, US 201762530095 P, 20170707 | EP pub. no. and date |
EP 3609540 20200219 | Effective date | | Applicant/owner | Bolt Biotherapeutics, Inc., 640 Galveston Drive
Redwood City, California 94063, US | Applicant ref. no. | P81704DK01 | Inventor | JACKSON, David Y., 2764 Waltham Cross Street
Belmont, California 94002, US, ALONSO, Michael N., 1109 Pomeroy Avenue
Santa Clara, California 95051, US, LEE, Arthur, 770 N. Winchester Boulevard, 19
San Jose, California 95128, US, LAURA, Richard P., 725 27th Avenue
San Mateo, California 94403, US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 47/55 (2017.01) , A61K 47/68 (2017.01) , A61P 35/00 (2006.01) , C07K 16/28 (2006.01) , C07K 16/30 (2006.01) , C07K 16/32 (2006.01) | Title | FREMGANGSMÅDE TIL IMMUNKONJUGATSYNTESE | Int. application no. | US2018027771 | Int. publication no. | WO2018191746 | Related patent (certificate) | | Status | Rettet DK/EP patent | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|